Sickle Cell Disease Association of America presents treatment seminar

HANOVER, Md.—The Sickle Cell Disease Association of America, a national nonprofit membership organization that advocates for people affected by sickle cell disease, will present the second seminar in the association’s “Sickle Cell Disease Masterclass: On the Cusp of a Cure” series. The free seminar, “All Things Considered – SCD Treatment: A Personal Choice,” will be livestreamed Aug. 24 at 3 p.m. Eastern time.

The seminar will feature a panel of speakers who will share their experiences living with sickle cell disease and the considerations of choosing disease-modifying treatments and curative therapies. Co-hosting the panel will be Teonna Woolford, founder and CEO of The Sickle Cell Reproductive Health Education Directive, who lives with sickle cell anemia, and Dr. Wanda Whitten-Shurney, CEO and medical director of the Michigan chapter of the Sickle Cell Disease Association of America.

The panel discussion will last from 3 to 4 p.m. followed by questions and answers from 4 to 4:30 p.m. Eastern time.

To enroll in the seminar, visit SCDAAmasterclass.com.

Sickle cell disease is an inherited blood disease causing red blood cells to take a sickle shape, which leads to blockages that prevent blood from reaching parts of the body. As a result, people with sickle cell complications can experience anemia, jaundice, gallstones, stroke, chronic pain, organ damage and premature death. No universal cure exists.

Sickle Cell Disease Association of America advocates for people affected by sickle cell conditions and empowers community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure. The association and more than 50 member organizations support sickle cell research, public and professional health education and patient and community services. (www.sicklecelldisease.org)